INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

27,371 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$74K
2,344 sh
Dec 5, 2025
Page 623 of 685
← PrevNext →
Dec 5, 2025
traded Dec 5, 2025
+0d
SEC Form 4

Evidence

15
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
1,673 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

15
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$62K
1,989 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

15
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
1,373 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

14
CM
Campbell Lisa MDirector
DTDynatrace, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
253 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

13
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
1,200 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

13
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
1,110 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

11
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$6,075
194 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

11
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
824 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

11
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$10K
323 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

9
GC
Gibson ChristopherDirector, Chief Executive Officer
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$185K
40.0K sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

8
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$146K
7,766 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

8
MJ
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER
OMCLOMNICELL, INC.
Open-market sale · 10b5-1 plan
SELL$244K
6,106 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

8
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$146K
7,767 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

8
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
1,004 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

7
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$819K
45.0K sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

7
BM
Barrett David MichaelDirector, Chief Executive Officer
EXFYExpensify, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
30.0K sh
Dec 1, 2025Dec 5, 2025
traded Dec 1, 2025
+4dSEC Form 4

Evidence

50
DS
Dyer SimonDirector
SGISOMNIGROUP INTERNATIONAL INC.
Open-market purchase
BUY$2.77M
29.7K sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

49
FB
Fiol Andrew BSr Executive Vice President
FULTFULTON FINANCIAL CORP
Open-market purchase
BUY$4,237
249 sh
Jun 6, 2025Dec 4, 2025
traded Jun 6, 2025
+181dSEC Form 4

Evidence

48
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Open-market sale
SELL$51K
3,813 sh
Nov 24, 2025Dec 4, 2025
traded Nov 24, 2025
+10dSEC Form 4

Evidence

45
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
2,378 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

45
FB
Fiol Andrew BSr Executive Vice President
FULTFULTON FINANCIAL CORP
Open-market purchase
BUY$4,942
256 sh
Sep 11, 2025Dec 4, 2025
traded Sep 11, 2025
+84dSEC Form 4

Evidence

45
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
793 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

45
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
2,378 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

45
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$82K
994 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

45
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$82K
994 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

44
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$575K
7,335 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

44
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$487K
6,277 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

44
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$487K
6,277 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

44
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$575K
7,335 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

43
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.37M
30.2K sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

43
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.00M
25.8K sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

43
RS
Robertson StephenDirector
THTarget Hospitality Corp.
Open-market purchase
BUY$993K
125.0K sh
Dec 3, 2025Dec 4, 2025
traded Dec 3, 2025
+1dSEC Form 4

Evidence

42
NT
Notman TaliCHIEF REVENUE OFFICER
FROGJFrog Ltd
Open-market sale
SELL$863K
14.2K sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

42
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
285 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

42
VC
Vieira CoryChief Accounting Officer
PGYPagaya Technologies Ltd.
Open-market sale
SELL$195K
8,442 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

42
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$7,739
95 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

42
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3,290
40 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

42
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$9,787
119 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

42
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$7,739
95 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence